|
1
|
World Cancer Report 2014. World Health
Organization. Chapter 1.1. 2014
|
|
2
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Verdecchia A, Francisci S, Brenner H,
Gatta G, Micheli A, Mangone L and Kunkler I; EUROCARE-4 Working
Group: Recent cancer survival in Europe: a 2000–02 period analysis
of EUROCARE-4 data. Lancet Oncol. 8:784–796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kostova I: Platinum complexes as
anticancer agents. Recent Pat Anticancer Drug Discov. 1:1–22. 2006.
View Article : Google Scholar
|
|
6
|
Liu Y, Li M, Zhang G and Pang Z:
MicroRNA-10b overexpression promotes non-small cell lung cancer
cell proliferation and invasion. Eur J Med Res. 18:412013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang
Y, Ye S, Wu S, Zhong G, Ren J, et al: MicroRNA-143 inhibits
migration and invasion of human non-small-cell lung cancer and its
relative mechanism. Int J Biol Sci. 9:680–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT
and Zhang CP: MicroRNAs contribute to the chemoresistance of
cisplatin in tongue squamous cell carcinoma lines. Oral Oncol.
46:317–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sorrentino A, Liu C-G, Addario A, Peschle
C, Scambia G and Ferlini C: Role of microRNAs in drug-resistant
ovarian cancer cells. Gynecol Oncol. 111:478–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hui AB, Shi W, Boutros PC, Miller N,
Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et
al: Robust global micro-RNA profiling with formalin-fixed
paraffin-embedded breast cancer tissues. Lab Invest. 89:597–606.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun M, Liu XH, Li JH, Yang JS, Zhang EB,
Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: MiR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27(kip1). Mol Cancer Ther. 11:842–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang F, Tang J, Zhuang X, Zhuang Y, Cheng
W, Chen W, Yao H and Zhang S: MiR-196a promotes pancreatic cancer
progression by targeting nuclear factor kappa-B-inhibitor alpha.
PLoS One. 9:e878972014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du W, Ma XL, Zhao C, Liu T, Du YL, Kong
WQ, Wei BL, Yu JY, Li YY, Huang JW, et al: Associations of single
nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499
with colorectal cancer susceptibility. Asian Pac J Cancer Prev.
15:1047–1055. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoffman AE, Zheng T, Yi C, Leaderer D,
Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA
miR-196a-2 and breast cancer: a genetic and epigenetic association
study and functional analysis. Cancer Res. 69:5970–5977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu H, Zhu X, Cheng G, Zhou M and Lou W:
Downregulation of microRNA-21 enhances radiosensitivity in
nasopharyngeal carcinoma. Exp Ther Med. 9:2185–2189.
2015.PubMed/NCBI
|
|
18
|
Zhang SZ, Pan FY, Xu JF, Yuan J, Guo SY,
Dai G, Xue B, Shen WG, Wen CJ, Zhao DH and Li CJ: Knockdown of
c-Met by adenovirus-delivered small interfering RNA inhibits
hepatocellular carcinoma growth in vitro and in vivo. Mol Cancer
Ther. 4:1577–1584. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garofalo M and Croce CM: MicroRNAs as
therapeutic targets in chemoresistance. Drug Resist Updat.
16:47–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Raman V, Martensen SA, Reisman D, Evron E,
Odenwald WF, Jaffee E, Marks J and Sukumar S: Compromised HOXA5
function can limit p53 expression in human breast tumours. Nature.
405:974–978. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al:
The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Cell. 124:1169–1181.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu L, Fan J and Belasco JG: MicroRNAs
direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA.
103:4034–4039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amaral JD, Xavier JM, Steer CJ and
Rodrigues CM: Targeting the p53 pathway of apoptosis. Curr Pharm
Des. 16:2493–2503. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dykxhoorn DM: MicroRNAs and metastasis:
little RNAs go a long way. Cancer Res. 70:6401–6406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar
|
|
29
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar
|
|
30
|
Chen C, Zhang Y, Zhang L, Weakley SM and
Yao Q: MicroRNA-196: critical roles and clinical applications in
development and cancer. J Cell Mol Med. 15:14–23. 2011. View Article : Google Scholar
|
|
31
|
Suh YE, Raulf N, Gäken J, Lawler K, Urbano
TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M:
MicroRNA-196a promotes an oncogenic effect in head and neck cancer
cells by suppressing annexin A1 and enhancing radioresistance. Int
J Cancer. 137:1021–1034. 2015. View Article : Google Scholar
|
|
32
|
Yang G, Han D, Chen X, Zhang D, Wang L,
Shi C, Zhang W, Li C, Chen X, Liu H, et al: MiR-196a exerts its
oncogenic effect in glioblastoma multiforme by inhibition of IκBα
both in vitro and in vivo. Neuro Oncol. 16:652–661. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang J, Zheng F, Yu G, Yin Y and Lu Q:
miR-196a targets netrin 4 and regulates cell proliferation and
migration of cervical cancer cells. Biochem Biophys Res Commun.
440:582–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Szafranska AE, Doleshal M, Edmunds HS,
Gordon S, Luttges J, Munding JB, Barth RJ Jr, Gutmann EJ,
Suriawinata AA, Marc Pipas J, et al: Analysis of microRNAs in
pancreatic fine-needle aspirates can classify benign and malignant
tissues. Clin Chem. 54:1716–1724. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Chen J, Chang P, LeBlanc A, Li D,
Abbruzzesse JL, Frazier ML, Killary AM and Sen S: MicroRNAs in
plasma of pancreatic ductal adenocarcinoma patients as novel
blood-based biomarkers of disease. Cancer Prev Res (Phila).
2:807–813. 2009. View Article : Google Scholar
|
|
37
|
Wang Y, Li Z, He C, Wang D, Yuan X, Chen J
and Jin J: MicroRNAs expression signatures are associated with
lineage and survival in acute leukemias. Blood Cells Mol Dis.
44:191–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Niinuma T, Suzuki H, Nojima M, Nosho K,
Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki
Y, et al: Upregulation of miR-196a and HOTAIR drive malignant
character in gastrointestinal stromal tumors. Cancer Res.
72:1126–1136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luthra R, Singh RR, Luthra MG, Li YX,
Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al:
MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR-196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
42
|
Hu Z, Liang J, Wang Z, Tian T, Zhou X,
Chen J, Miao R, Wang Y, Wang X and Shen H: Common genetic variants
in pre-microRNAs were associated with increased risk of breast
cancer in Chinese women. Hum Mutat. 30:79–84. 2009. View Article : Google Scholar
|
|
43
|
Yekta S, Shih IH and Bartel DP:
MicroRNA-directed cleavage of HOXB8 mRNA. Science. 304:594–596.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhan X, Wu W, Han B, Gao G, Qiao R, Lv J,
Zhang S, Zhang W, Fan W, Chen H, et al: Hsa-miR-196a2 functional
SNP is associated with severe toxicity after platinum-based
chemotherapy of advanced nonsmall cell lung cancer patients in a
Chinese population. J Clin Lab Anal. 26:441–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
